Arcadia Biosciences, Inc. — Director's Dealing 2019

Nov 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2019-11-14

Reporting Person: Plavan Matthew T (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-14	Common stock	P	1000	$4.0795	Acquired	13000	Direct